Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2011 3
2012 6
2013 12
2014 5
2015 8
2016 10
2017 3
2018 3
2019 9
2020 3
2021 6
2022 4
2023 5
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Results by year

Filters applied: . Clear all
Page 1
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators. Nyang'wa BT, et al. Among authors: du cros p. N Engl J Med. 2022 Dec 22;387(25):2331-2343. doi: 10.1056/NEJMoa2117166. N Engl J Med. 2022. PMID: 36546625 Clinical Trial.
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.
Berry C, du Cros P, Fielding K, Gajewski S, Kazounis E, McHugh TD, Merle C, Motta I, Moore DAJ, Nyang'wa BT. Berry C, et al. Among authors: du cros p. Trials. 2022 Jun 13;23(1):484. doi: 10.1186/s13063-022-06331-8. Trials. 2022. PMID: 35698158 Free PMC article.
Beyond the bubble: neighbours helping neighbours.
Lin YD, du Cros P, Greig J, Lavu EK, Hiasihri S. Lin YD, et al. Among authors: du cros p. Intern Med J. 2021 Jul;51(7):1013-1015. doi: 10.1111/imj.15416. Intern Med J. 2021. PMID: 34278685 No abstract available.
Person-centred care in TB.
Horter S, Daftary A, Keam T, Bernays S, Bhanushali K, Chavan D, Denholm J, Furin J, Jaramillo E, Khan A, Lin YD, Lobo R, Loveday M, Majumdar SS, Mistry N, Patel H, Rane S, Swaminathan A, Triasih R, Venkatesan N, Viney K, du Cros P. Horter S, et al. Among authors: du cros p. Int J Tuberc Lung Dis. 2021 Oct 1;25(10):784-787. doi: 10.5588/ijtld.21.0327. Int J Tuberc Lung Dis. 2021. PMID: 34615573 No abstract available.
Bedaquiline overdose: A case report.
Telnov O, Alvarez V, Graglia E, Molfino L, du Cros P, Rich M. Telnov O, et al. Among authors: du cros p. Int J Infect Dis. 2019 Jul;84:138-140. doi: 10.1016/j.ijid.2019.03.035. Epub 2019 Apr 2. Int J Infect Dis. 2019. PMID: 30951878 Free article.
Progress in Medicine: Experts Take Stock.
PLOS Medicine Editors; Beck A, Birney E, Graeber M, Tumwine J, Hay P, Ahn HS, Patel A, du Cros P, von Seidlein L, Wareham N, Low N. PLOS Medicine Editors, et al. Among authors: du cros p. PLoS Med. 2015 Dec 29;12(12):e1001933. doi: 10.1371/journal.pmed.1001933. eCollection 2015 Dec. PLoS Med. 2015. PMID: 26713445 Free PMC article.
Standards for clinical trials for treating TB.
du Cros P, Greig J, Alffenaar JC, Cross GB, Cousins C, Berry C, Khan U, Phillips PPJ, Velásquez GE, Furin J, Spigelman M, Denholm JT, Thi SS, Tiberi S, Huang GKL, Marks GB, Turkova A, Guglielmetti L, Chew KL, Nguyen HT, Ong CWM, Brigden G, Singh KP, Motta I, Lange C, Seddon JA, Nyang'wa BT, Maug AKJ, Gler MT, Dooley KE, Quelapio M, Tsogt B, Menzies D, Cox V, Upton CM, Skrahina A, McKenna L, Horsburgh CR, Dheda K, Marais BJ. du Cros P, et al. Int J Tuberc Lung Dis. 2023 Dec 1;27(12):885-898. doi: 10.5588/ijtld.23.0341. Int J Tuberc Lung Dis. 2023. PMID: 38042969 Free PMC article.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, Rajaram S, Rassool M, McHugh T, Spigelman M, Moore DA, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL team. Nyang'wa BT, et al. Among authors: du cros p. Lancet Respir Med. 2024 Feb;12(2):117-128. doi: 10.1016/S2213-2600(23)00389-2. Epub 2023 Nov 16. Lancet Respir Med. 2024. PMID: 37980911 Free article. Clinical Trial.
WHO recommendations for multidrug-resistant tuberculosis.
Berry C, Achar J, du Cros P. Berry C, et al. Among authors: du cros p. Lancet. 2016 Nov 5;388(10057):2234. doi: 10.1016/S0140-6736(16)32071-2. Lancet. 2016. PMID: 27825500 No abstract available.
78 results